BLU-667 trans form

Modify Date: 2024-01-05 23:13:11

BLU-667 trans form Structure
BLU-667 trans form structure
Common Name BLU-667 trans form
CAS Number 2097132-93-7 Molecular Weight 533.60
Density N/A Boiling Point N/A
Molecular Formula C27H32FN9O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BLU-667 trans form


cis-Pralsetinib (cis-Blu667) is a highly potent and selective inhibitor of rearranged during transfection (RET), with IC50 values ranging from 0.3 to 0.4 nM for WT RET and four enzyme variants (V804L, V804M, M918T, CCDC6-RET), and with broad, robust and anti-tumor activity against multiple RET-driven solid tumor types[1][2].

 Names

Name cis-Pralsetinib

 BLU-667 trans form Biological Activity

Description cis-Pralsetinib (cis-Blu667) is a highly potent and selective inhibitor of rearranged during transfection (RET), with IC50 values ranging from 0.3 to 0.4 nM for WT RET and four enzyme variants (V804L, V804M, M918T, CCDC6-RET), and with broad, robust and anti-tumor activity against multiple RET-driven solid tumor types[1][2].
Related Catalog
Target

IC50: 0.4 nM (WT RET), 0.3 nM (RET V804L), 0.4 nM (RET V804M), 0.4 nM (RET M918T), 0.4 nM (CCDC6-RET)[2]

References

[1]. http://www.blueprintmedicines.com/wp-content/uploads/2017/10/BLU-667-EORTC-2017-BPM.pdf

[2]. Subbiah V, et al. Precision Targeted Therapy With BLU-667 for RET-Driven Cancers. American Association for Cancer Research. 10.1158/2159-8290.CD-18-0338.

 Chemical & Physical Properties

Molecular Formula C27H32FN9O2
Molecular Weight 533.60